Graham Svoronos

(Ms. Dawn Svoronos)

Currently holds positions in PTC Therapeutics Inc, Xenon Pharmaceuticals Inc and Global Blood Therapeutics Inc

Positions
Position Company Period
Independent Director PTC Therapeutics Inc June 13, 2016 -
Independent Director Xenon Pharmaceuticals Inc Sept. 27, 2016 -
Independent Director Global Blood Therapeutics Inc Dec. 19, 2018 -
Director Endocyte Inc None -
Independent Director Medivation Inc Dec. 1, 2014 - Sept. 28, 2016
Interim Chief Commercial Officer, Director Medivation Inc July 10, 2014 - Dec. 1, 2014
Independent Director Medivation Inc April 1, 2013 - July 10, 2014
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2023-08-24 2023-08-24
S Sale
25,000 -50.0%
38.70
967,500 USD
25,000 -50.0% 38.70 967,500 USD
2023-05-11 2023-05-09
US ACELYRIN Inc (SLRN)
B Purchase
15,000 +inf%
18.00
270,000 USD
15,000 +inf% 18.00 270,000 USD
2022-06-22 2022-06-21
PS Planned sale
1,908 -26.2%
27.24
51,983 USD
1,908 -26.2% 27.24 51,983 USD
2022-06-10 2022-06-09
S Sale
738 -2.5%
27.20
20,074 USD
738 -2.5% 27.20 20,074 USD
2022-05-18 2022-05-16
B Purchase
30,000 +150.0%
0.85
25,578 USD
30,000 +150.0% 0.85 25,578 USD
2022-01-11 2022-01-07
S Sale
510 -1.9%
38.53
19,648 USD
510 -1.9% 38.53 19,648 USD
2021-06-21 2021-06-18
PS Planned sale
1,609 -30.4%
36.54
58,793 USD
1,609 -30.4% 36.54 58,793 USD
2021-06-11 2021-06-09
S Sale
365 -1.3%
41.89
15,288 USD
365 -1.3% 41.89 15,288 USD
2021-04-01 2021-03-31
B Purchase
20,000 +inf%
10.02
200,338 USD
20,000 +inf% 10.02 200,338 USD
2021-02-02 2021-02-01
S Sale
506 -1.8%
56.96
28,820 USD
506 -1.8% 56.96 28,820 USD
2020-06-19 2020-06-19
PS Planned sale
881 -28.1%
64.42
56,750 USD
881 -28.1% 64.42 56,750 USD
2020-06-19 2020-06-19
PS Planned sale
1,663 -34.6%
63.69
105,913 USD
1,663 -34.6% 63.69 105,913 USD
2020-06-12 2020-06-11
S Sale
364 -1.4%
48.36
17,603 USD
364 -1.4% 48.36 17,603 USD